Mass spectrometry imaging of pharmacological compounds in tissue sections

Goodwin, R.J.A. and Pitt, A.R. (2010) Mass spectrometry imaging of pharmacological compounds in tissue sections. Bioanalysis, 2(2), pp. 279-293. (doi: 10.4155/bio.09.180)

Full text not currently available from Enlighten.

Publisher's URL: http://dx.doi.org/10.4155/bio.09.180

Abstract

The use of MS imaging (MSI) to resolve the spatial and pharmacodynamic distributions of compounds in tissues is emerging as a powerful tool for pharmacological research. Unlike established imaging techniques, only limited a priori knowledge is required and no extensive manipulation (e.g., radiolabeling) of drugs is necessary prior to dosing. MS provides highly multiplexed detection, making it possible to identify compounds, their metabolites and other changes in biomolecular abundances directly off tissue sections in a single pass. This can be employed to obtain near cellular, or potentially subcellular, resolution images. Consideration of technical limitations that affect the process is required, from sample preparation through to analyte ionization and detection. The techniques have only recently been adapted for imaging and novel variations to the established MSI methodologies will further enhance the application of MSI for pharmacological research.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Pitt, Dr Andrew and Goodwin, Dr Richard
Authors: Goodwin, R.J.A., and Pitt, A.R.
College/School:College of Medical Veterinary and Life Sciences > Institute of Molecular Cell and Systems Biology
Journal Name:Bioanalysis
ISSN:1757-6180

University Staff: Request a correction | Enlighten Editors: Update this record